Boston Scientific expand vascular supply chain by acquiring Penumbra for $14.5 billion, broadening its vascular and neurovascular technology portfolio.

Amplifi Vascular, Inc., a developer of solutions for hemodialysis vascular access, announced it has been granted Breakthrough ...

Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.

The Port of Los Angeles — which is undertaking the $130 million development that’s been ongoing since 2024 and is slated to finish late this year — opened the new northbound on-ramp to the 110 Freeway ...

EQT Life Sciences has exited its investment in Vivasure Medical following the sale of the Irish medical technology company to Haemonetics. Backed by EQT since 2016, Vivasure developed the PerQseal® ...

C.R. Bard Inc. failed to convince the Federal Circuit to revive a decade-old patent lawsuit against AngioDynamics Inc., a rival maker of vascular access ports. A Delaware federal judge correctly found ...

The Veris Cancer Care Platform to be deployed to enhance personalized cancer care in patients undergoing systemic cancer therapy across OSUCCC – James "We are pleased to move into the commercial phase ...

The FDA has labeled Smiths Medical‘s recall of ProPort Implantable Plastic Port as Class I, the most serious kind. Smiths Medical — which is part of ICU Medical — recalled its ProPort ports because of ...

The following is a summary of “Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study,” published in the February 2025 ...